4 products found
Benevolent Products
-
Benevolent - The Benevolent Platform
The Benevolent Platform™ is our powerful computational R&D platform. At its core sits our Knowledge Graph, which captures the interconnectivity of all relevant available data and scientific literature. Our suite of exploratory and ...
-
Covid-19
The emerging global threat from COVID-19 demanded immediate action. With cases rising rapidly, we set up a specialist team to use our AI-drug discovery platform to search for existing drugs — already proven safe — that could be repurposed to treat the virus. We are the only AI company to successfully identify a drug to treat COVID-19. Together by building bespoke drug repurposing workflow customisations, we used our Knowledge Graph and AI ...
-
Atopic Dermatitis
Advancing a potent and selective Atopic Dermatitis treatment through the clinic. What is Atopic Dermatitis? Atopic Dermatitis (AD), the most common type of eczema, is a chronic relapsing inflammatory skin disease that results in itchy, red, swollen, and cracked skin. Our work : BEN-2293, a Pan-Trk antagonist, is being developed to treat AD without the need to use topical steroids and designed to address the debilitating itch and inflammation in both ...
-
Ulcerative Colitis
Better target discovery and compound design in Ulcerative Colitis. What is UC?: Ulcerative colitis (UC) is a chronic, lifelong disease that causes inflammation and ulceration of the inner lining of the colon and rectum, accompanied by debilitating symptoms. Our work: There is no cure for UC, current treatments have side effects and don’t work on all patients. Our work focuses on developing safer and more effective oral small molecule treatments. ...